meningococcal vaccine
Selected indexed studies
- High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine. (MMWR Morb Mortal Wkly Rep, 2017) [PMID:28704351]
- Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis. (J Infect, 2024) [PMID:38986746]
- Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies. (Expert Rev Vaccines, 2020) [PMID:32321332]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine. (2017) pubmed
- Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis. (2024) pubmed
- Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies. (2020) pubmed
- The United Kingdom meningococcal vaccine (4CMenB) programme against gonorrhoea: A review of the evidence and knowledge gaps. (2025) pubmed
- A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT). (2025) pubmed
- Meningococcal vaccine in travelers. (2007) pubmed
- Meningococcal vaccine evolution. (2012) pubmed
- Meningococcal Vaccine in Mali and Gambia. (2023) pubmed
- Predictors of meningococcal vaccine uptake in university and college students: a systematic review and meta-analysis. (2022) pubmed
- Meningococcal vaccine for infants? (2012) pubmed